SG11201405778WA - Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections - Google Patents

Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections

Info

Publication number
SG11201405778WA
SG11201405778WA SG11201405778WA SG11201405778WA SG11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA
Authority
SG
Singapore
Prior art keywords
vaginal
prevention
treatment
amphoteric surfactants
biofilms
Prior art date
Application number
SG11201405778WA
Other languages
English (en)
Inventor
Christoph Abels
Ulrich Knie
Michael Soeberdt
Original Assignee
Wolff August Gmbh & Co Kg Arzneimittel Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolff August Gmbh & Co Kg Arzneimittel Dr filed Critical Wolff August Gmbh & Co Kg Arzneimittel Dr
Publication of SG11201405778WA publication Critical patent/SG11201405778WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201405778WA 2012-03-19 2013-03-19 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections SG11201405778WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261612680P 2012-03-19 2012-03-19
EP12160058 2012-03-19
PCT/EP2013/055706 WO2013139796A1 (en) 2012-03-19 2013-03-19 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections

Publications (1)

Publication Number Publication Date
SG11201405778WA true SG11201405778WA (en) 2014-10-30

Family

ID=49221873

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405778WA SG11201405778WA (en) 2012-03-19 2013-03-19 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections

Country Status (13)

Country Link
US (1) US20150164837A1 (es)
EP (1) EP2827854A1 (es)
JP (1) JP2015510914A (es)
KR (1) KR20150002676A (es)
CN (1) CN104244942A (es)
AU (1) AU2013237576A1 (es)
CA (1) CA2865687A1 (es)
HK (1) HK1201189A1 (es)
MX (1) MX2014011218A (es)
NZ (1) NZ630347A (es)
RU (1) RU2014141897A (es)
SG (1) SG11201405778WA (es)
WO (1) WO2013139796A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3308771A1 (en) 2012-06-13 2018-04-18 Evofem, Inc. Compositions and methods for enhancing the efficacy of contraceptive microbicides
JP2017078029A (ja) * 2015-10-19 2017-04-27 アース製薬株式会社 殺菌方法及び殺菌組成物
CN110225750A (zh) * 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 细菌性阴道病的治疗和预防方法
MX2021000984A (es) * 2018-07-31 2021-04-12 Kimberly Clark Co Composicion que incluye un agente potenciador antimicrobiano que incluye un anfocarboxilato y metodos para aumentar la efectividad antimicrobiana de una composicion.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405323A (en) * 1981-09-08 1983-09-20 Sidney Auerbach Sanitary napkin
WO1990007325A1 (en) * 1988-12-30 1990-07-12 Edko Trading And Representation Company Limited A pessary containing antibacterial drugs
GB9810949D0 (en) * 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
US6723308B2 (en) * 2001-11-02 2004-04-20 Kenra, Llc Hair clarifying treatment
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
MX2007016588A (es) * 2005-05-20 2008-03-11 Rhodia Composiciones surfactantes estructuradas.
ES2588437T3 (es) 2007-11-30 2016-11-02 Toltec Pharmaceuticals, Llc Composiciones y métodos para tratar infecciones vaginales y biopelículas vaginales patógenas
WO2010077628A2 (en) * 2008-12-08 2010-07-08 The Procter & Gamble Company Personal care composition in the form of an atricle having a porous, dissolvable solid structure

Also Published As

Publication number Publication date
JP2015510914A (ja) 2015-04-13
MX2014011218A (es) 2015-04-10
CN104244942A (zh) 2014-12-24
AU2013237576A1 (en) 2014-09-25
HK1201189A1 (en) 2015-08-28
US20150164837A1 (en) 2015-06-18
CA2865687A1 (en) 2013-09-26
RU2014141897A (ru) 2016-05-20
NZ630347A (en) 2016-04-29
EP2827854A1 (en) 2015-01-28
KR20150002676A (ko) 2015-01-07
WO2013139796A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
HRP20181364T1 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
HK1204914A1 (en) Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
PT2667849T (pt) Composição efervescente em forma sólida para utilização em aplicações vaginais para o tratamento de infeções vaginais
HK1209195A1 (en) Contact lens use in the treatment of an ophthalmologic condition
PL2627334T3 (pl) Kompozycje do stosowania w leczeniu zakażeń wirusowych
GB201319621D0 (en) Antimicrobial agents and their use in therapy
PT2854910T (pt) Níveis de ceramida no tratamento e prevenção de infeções
EP2841064A4 (en) USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF DISEASES AND INJURIES
GB2515439B (en) Vesicular formulations for use in the treatment of reduced mobility
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1201189A1 (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
LT2845598T (lt) Preparatas, skirtas naudoti netipinės osteoporozės prevencijai ir gydymui
EP2709630A4 (en) PAR1 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF PARAMYXOVIRIDAE INFECTIONS
HK1214511A1 (zh) 鹽酸蘭地洛爾在快速性心律失常的長期治療中的用途
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
ZA201308025B (en) The use of secnidazole in treating dental infections
SI2771016T1 (sl) Primicin in njegove komponente za uporabo pri zdravljenju ali preventivi okužb povzročenimi s specifičnimi patogeni
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
GB201208770D0 (en) Compounds for use in the treatment of adenovirus infections